This tool guides women on when to add MRI to their breast cancer screening regiment.
Author: Kelly Casey
Dr. Duska's goal is for every GYN cancer patient at UVA Health to have the opportunity to participate in a clinical trial.
The discovery of an unexpected oocyte protein on the surface of cancer cells may lead to new treatments for pancreatic, ovarian, and other cancers.
UVA Health launches 2 key clinical trials to see if immunotherapy combined with FUS tumor ablation can prevent breast cancer metastasis.
With a first-of-its-kind focused ultrasound center & trials, UVA Health is positioned to overcome immunotherapy’s cancer-metastases limitation.
Todd Bauer, MD, leads a laboratory searching for what drives chemo-resistance and metastases in his pancreatic and colorectal cancer patients.
With acute myeloid leukemia classification overseen by 3 separate guidelines, Firas El Chaer, MD, is working to bring order to the chaos.
Thomas Loughran, MD, reveals the most intriguing clinical applications for his LGL and acute myeloid leukemias research.
This first-ever trial to explore pelvic floor and sexual health outcomes in women after bladder removal surgery delivers notable insights.
UVA Health audiologists developed a novel approach to detect hearing loss in children with developmental delays. No ABR assessment required.